The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights
There is an increased cardiovascular (CV) risk in axial spondyloarthritis (axSpA), leading to increased CV mortality and morbidity in these patients. The factors that may explain this enhanced CV risk in axSpA are multiple, including traditional CV risk factors such as smoking, but also the inflamma...
Guardado en:
Autor principal: | Eric Toussirot |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/66187b3dab6242fa934d5124bea97556 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acute transverse myelitis revealing ankylosing spondylitis: A case report and literature review
por: Soumaya Boussaid, et al.
Publicado: (2021) -
Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
por: Amel Rezgui, et al.
Publicado: (2021) -
Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy
por: Marin J, et al.
Publicado: (2018) -
The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
por: Heslinga SC, et al.
Publicado: (2018) -
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
por: Milena Iwaszko, et al.
Publicado: (2021)